Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04227977 · ClinicalTrials.gov registry record · NA
Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)
A NA study, sponsored by 3ive Labs.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04227977 is a NA study that has completed, run by 3ive Labs. The registered enrollment target is 8 participants.
The verdict
NCT04227977, a NA study, has completed, sponsored by 3ive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The Cardiorenal Syndrome during Acute decompensated heart failure (ADHF) with persistent congestion despite high dose IV diuretic therapy is associated with remarkable morbidity, which can include the need for renal dialysis or ultrafiltration, an increased length of stay, and high mortality rates. The aims and purpose of this feasibility clinical research trial are: 1. to evaluate the safety profiles associated with performing negative pressure diuresis for the treatment of hypervolemia associated with the cardiorenal syndrome during ADHF with persistent congestion despite high dose IV diuretic therapy via the investigational JuxtaFlow® System, and 2. to evaluate the effectiveness of the investigational JuxtaFlow System in treatment of hypervolemia associated with ADHF.
Interventions
- DEVICE JuxtaFlow System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2023-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04227977
The ClinicalTrials.gov registry entry for NCT04227977 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3ive Labs, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JuxtaFlow System is the first listed.
NCT04227977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04227977 about?
NCT04227977 is a clinical study titled "Volume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)". The Cardiorenal Syndrome during Acute decompensated heart failure (ADHF) with persistent congestion despite high dose IV diuretic therapy is associated with remarkable morbidity, which can include the need for renal dialysis or ultrafiltration, an increased length of stay, and high mortality rates. ...
What is the current status of trial NCT04227977?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-06-12. Estimated completion is 2023-10-20.
What interventions are being tested in trial NCT04227977?
The interventions under investigation include: JuxtaFlow System (DEVICE).
Who is sponsoring clinical trial NCT04227977?
This trial is sponsored by 3ive Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.